AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metindia GP 1mg/1000mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Bajaj Pharmaceutical

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Metindia GP 1mg/1000mg Tablet ER

Glucovance ER 1mg/1000mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This formulation helps regulate blood glucose. Administer Glucovance ER with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled glucose levels; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating dietary modifications, physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Primary Ingredients of Metindia GP 1mg/1000mg Tablet ER

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Metindia GP 1mg/1000mg Tablet ER

Managing type 2 diabetes

Major Benefits of Metindia GP 1mg/1000mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Metindia GP 1mg/1000mg Extended-Release Tablet with food.

Common Side effects of Metindia GP 1mg/1000mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metindia GP 1mg/1000mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metindia GP 1mg/1000mg Extended-Release tablets with a meal.

How Metindia GP 1mg/1000mg Tablet ER works:

Metformin and glimepiride are combined in the extended-release Metindia GP 1mg/1000mg tablet. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Metindia GP 1mg/1000mg Extended-Release tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Metindia GP 1mg/1000mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Metindia GP tablets (1mg/1000mg) are contraindicated for use while breastfeeding due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar fluctuations.

KidneyKidneyCAUTION

Exercise caution when prescribing Metindia GP 1mg/1000mg Extended-Release tablets to individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is advised. The use of Metindia GP 1mg/1000mg Extended-Release tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Metindia GP 1mg/1000mg Extended-Release tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate therapy with a reduced Metindia GP 1mg/1000mg ER tablet dosage; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Metindia GP 1mg/1000mg Tablet ER :

Should you forget to take your Metindia GP 1mg/1000mg Extended-Release tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metindia GP 1mg/1000mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metindia GP 1mg/1000mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Metindia GP 1mg/1000mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Metindia GP 1mg/1000mg Tablet ER and seek immediate medical attention.
Metindia GP 1mg/1000mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Metindia GP 1mg/1000mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Metindia GP 1mg/1000mg Tablet ER can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental Vitamin B12 intake is recommended by some researchers.
Metindia GP 1mg/1000mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concomitant use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Metindia GP 1mg/1000mg Tablet ER with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Metindia GP 1mg/1000mg Ta...
57
MRP 66
14% off